Antimalarial drug artemisinin stabilizes PfRACK1 binding to the ribosome
Structure · 2025-08 · 33 (8) · 1386-1397.e5
DOI: 10.1016/j.str.2025.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structure, 2025-08. Verfasst von Ka Diam Go und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore. Hauptthemen laut MEDLINE: Artemisinins, Plasmodium falciparum, Ribosomes, Antimalarials. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Medical Research Council, Government of Singapore Ministry of Education, National Research Foundation.
Abstract (Originalsprache)
Artemisinin and its derivatives represent the core agents in artemisinin combination therapies that are the current frontline treatment for P. falciparum and P. vivax malaria infections. Artemisinins are known to bind a wide array of proteins that disrupt the parasite's cellular physiology. Here, we show that artemisinins' cytotoxic activity involves structural alteration of key P. falciparum macromolecular complexes, including the ribosome, proteasome, and T-complex. The structural analysis revealed that, following artemisinin treatment, a larger population of Pf80S ribosomes binds PfRACK1. Unlike in most eukaryotes, PfRACK1 does not interact with the C-terminal tail of the r-protein uS3 that in Plasmodium is truncated. This likely suggests an evolved role of uS3 in facilitating RACK1-mediated translational regulation, which would potentially benefit the parasite under certain conditions. Stabilization of RACK1 ribosome interaction likely contributes to artemisinins' mode of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore.
- School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore; NTU Institute of Structural Biology, Nanyang Technological University, Singapore 636921, Singapore.
- Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC 3052, Australia.
- School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore; NTU Institute of Structural Biology, Nanyang Technological University, Singapore 636921, Singapore; Antimicrobial Resistance…
- School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore. Electronic address: zbozdech@ntu.edu.sg.
- School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore; NTU Institute of Structural Biology, Nanyang Technological University, Singapore 636921, Singapore. Electronic address: ygao@…
Förderung
- National Medical Research Council
- Government of Singapore Ministry of Education
- National Research Foundation
Zitieren
APA
Go, K. D., Yan, X. F., Wirjanata, G., Ero, R., Pazicky, S., Dziekan, J., Tjia, S., Lescar, J., Bozdech, Z., & Gao, Y. G. (2025). Antimalarial drug artemisinin stabilizes PfRACK1 binding to the ribosome. Structure, 33(8), 1386-1397.e5. https://doi.org/10.1016/j.str.2025.05.008
Vancouver
Go KD, Yan XF, Wirjanata G, Ero R, Pazicky S, Dziekan J, et al. Antimalarial drug artemisinin stabilizes PfRACK1 binding to the ribosome. Structure. 2025;33(8):1386-1397.e5. doi:10.1016/j.str.2025.05.008
BibTeX
@article{Go2025,
author = {Go, Ka Diam and Yan, Xin-Fu and Wirjanata, Grennady and Ero, Rya and Pazicky, Samuel and Dziekan, Jerzy and Tjia, Seth and Lescar, Julien and Bozdech, Zbynek and Gao, Yong-Gui},
title = {Antimalarial drug artemisinin stabilizes PfRACK1 binding to the ribosome},
journal = {Structure},
year = {2025},
volume = {33},
number = {8},
pages = {1386--1397.e5},
doi = {10.1016/j.str.2025.05.008}
}
EUVIMED